Vision Technologies Touchless Visual Communication and Collaboration Solutions Enable Employees to Return to Work Safely

Vision Technologies Touchless Visual Communication and Collaboration Solutions Enable Employees to Return to Work Safely

GLEN BURNIE, MD, September 11, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, is helping companies prepare for employees to return to work safely and securely. Vision’s Touchless Visual Communication and Collaboration (TVCC) solutions are designed to create a safe and secure touchless meeting experience where people can communicate and collaborate seamlessly and with ease with in the room, remotely, or both. Room system and digital signage solutions enable organizations to reinforce occupancy and social distancing policies and share important real-time health and safety information from a range of integrated solutions. With a comprehensive TVCC solution in place, organizations can prepare their staff for a safe, secure and productive return to work. ...  Read more

GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo

GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo

GlycoT Therapeutics has signed a sublicense agreement for its glycoengineering technology with Daiichi Sankyo.
The agreement grants Daiichi Sankyo worldwide and nonexclusive rights to intellectual property that GlycoT currently licenses from the University of Maryland system. The deal includes an undisclosed upfront payment, annual fees, and royalties on sales of GlycoT.
The enzymatic glycoengineering technology platform allows scientists to precisely change and modify the sugars on monoclonal antibodies. Daiichi Sankyo plans to use the technology in the development of new drug candidates. ...  Read more

Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors

Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors

FREDERICK, Md.–(BUSINESS WIRE)–Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Alex Martin as Chairman of the Board of Directors. ...  Read more

Elixirgen Scientific Opens Japan Office and Strengthens Partnership with Ricoh

Elixirgen Scientific Opens Japan Office and Strengthens Partnership with Ricoh

Elixirgen Scientific, Inc. is pleased to announce the opening of a new Japanese office located  in Kawasaki city, Kanagawa Prefecture. The Japan office will allow Elixirgen Scientific to support a growing demand for induced pluripotent stem cell (iPSC) differentiation technologies in Japan and throughout the Asia/Pacific region. This is an important milestone as it is the company’s first expansion outside of the headquarters in Baltimore, Maryland, USA. ...  Read more

BioFactura Awarded $1 Million SBIR Contract for Development of a Marburg Virus Therapeutic

BioFactura Awarded $1 Million SBIR Contract for Development of a Marburg Virus Therapeutic

FREDERICK, MARYLAND, JULY 27, 2020: BioFactura, Inc. today announced a $1 million Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). The goal of this project is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid manufacture of a monoclonal antibody (mAb) therapeutic against the Marburg virus (MARV) biothreat. ...  Read more

KatzAbosch releases COVID-19 survey

KatzAbosch releases COVID-19 survey

Columbia-based KatzAbosch has released a Medical Community COVID-19 Survey to get a sense of how medical practices are responding to the COVID-19 crisis. The firm asked approached its medical clients and contacts to participate in this peer survey in order to provide general benchmarking data to the community and all local practices around the impact COVID-19 has had on the medical industry. ...  Read more

Vision Technologies Integrates Screening, Protection and Tracing Solutions as Employees Return to Work

Vision Technologies Integrates Screening, Protection and Tracing Solutions as Employees Return to Work

GLEN BURNIE, MD, July 13, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, is helping companies prepare for employees to return to work safely and securely. As organizations implement Return to Work (RTW) strategies in the face of the global pandemic, a Screening, Protection and Tracing (SPT) plan is critical to protecting employees, visitors, and the broader community. The plan needs to be flexible, yet in accordance with state and local regulations and recommendations. ...  Read more